Xeris Biopharma Holdings, Inc.
← Back to XERS Overview

Xeris Biopharma Holdings, Inc. (XERS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

110.69

Financial Fundamentals

XERSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-03-31-2.21
2017-06-30-1.95
2017-09-30-1.36
2017-12-31-1.14
2018-03-31-0.92
2018-06-30-1.55
2018-09-30-2.39
2018-12-31-4.34
2019-03-31-2.27
2019-06-30-2.26
2019-09-30-2.01
2019-12-31-1.43
2020-03-31-0.55
2020-06-30-1.06
2020-09-30-4.24
2020-12-31-3.00
2021-03-31-3.76
2021-06-30-2.48
2021-09-30-1.57
2021-12-31-1.74
2022-03-31-2.56
2022-06-30-2.03
2022-09-30-2.44
2022-12-31-3.50
2023-03-31-3.40
2023-06-30-4.68
2023-09-30-5.27
2023-12-31-6.06
2024-03-31-3.82
2024-06-30-5.42
2024-09-30-6.48
2024-12-31-24.71
2025-03-31-22.69
2025-06-30-96.49
2025-09-30678.33
2025-12-3129.38
2026-03-31110.69

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.